MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SALACH, J. I.
Right arrow Articles by YOUDIM, M. B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SALACH, J. I.
Right arrow Articles by YOUDIM, M. B. H.

Molecular Pharmacology, Vol 16, 234-241, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

The Reaction of Bovine and Rat Liver Monoamine Oxidase with [14C]-Clorgyline and [14C]-Deprenyl

JAMES I. SALACH 1, KRISTINA DETMER 1, and MOUSSA B. H. YOUDIM 2

1 Molecular Biology Division, Veterans Administration Hospital, San Francisco, California 94121
2 Technion, Faculty of Medicine, Department of Pharmacology, Bat-Galim, Haifa, Israel

Highly purified monoamine oxidase from beef and rat liver has been compared with regard to the presence of A and B type enzymes. The beef enzyme oxidizes B and A-B type substrates rapidly and A type substrates slowly in both membrane ahd soluble preparations. Deprenyl, a selective inhibitor of the B type enzyme, inhibits it at very low concentrations and the I50 for inhibition is about the same with A, B, and A-B type substrates. Clorgyline, a selective inhibitor of the A type enzyme, inhibits only at high concentrations, and the I50 value is again independent of the substrate used. This shows that only the B type enzyme occurs in beef liver. Rat liver, in contrast, contains both A and B type of monoamine oxidase. Deprenyl inhibits the oxidation of B substrates at low concentrations, and clorgyline inhibits oxidation of A substrates at low concentrations, while biphasic inhibition is seen with A-B substrates upon titration with either inhibitor. Deprenyl and pargyline are stoichiometrically bound to the beef and rat liver enzymes, but clorgyline is bound to the beef enzyme in amounts in considerable stoichiometric excess indicating nonspecific binding. The enzyme from both sources binds these acetylenic suicide inhibitors at N-5 of the covalently bound flavin in a flavocyanine linkage. No conversion of the A to the B type of enzyme on extraction of the enzyme from the membrane and removal of lipids has been noted.

Submitted on September 19, 1978
Accepted on January 12, 1979




This article has been cited by other articles:


Home page
 J. Neurosci.Home page
P. Maher and J. B. Davis
The Role of Monoamine Metabolism in Oxidative Glutamate Toxicity
J. Neurosci., October 15, 1996; 16(20): 6394 - 6401.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics